This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MARVIN L. MEITUS, M.D.; PHILIP WASSERMAN, M.D.

AMA Arch Intern Med. 1953;91(4):464-473.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IS LIVER damage caused by anticoagulant therapy, especially if such therapy is prolonged? Though numerous problems have arisen since the introduction of this newer treatment, the question propounded has provoked considerable controversy.

Even if overdosage is not a factor, the likelihood of serious damage to the liver, kidney, or other organs during the prolonged administration of bishydroxycoumarin (Dicumarol) has been considered by several workers. In a preliminary report, in 1946, Wright¹ described his experience with bishydroxycoumarin in the treatment of coronary thrombosis. In his series of 76 patients, 15 died, and autopsies were performed on 8. The livers from three of the subjects showed slight fatty infiltration, which was not believed to be of serious degree. It should be noted, however, that in these autopsied subjects, no laboratory or clinical evaluation of liver function was described.

Three years following Wright's report, Foley and Wright² studied a group of . . . [Full Text PDF of this Article]

Author Affiliations
MIAMI BEACH, FLA.; CINCINNATI With the Technical Assistance of Helen Playfair, Cincinnati

From the Departments of Clinical Laboratory and Internal Medicine, the Jewish Hospital, Cincinnati.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?